<DOC>
	<DOCNO>NCT02066363</DOCNO>
	<brief_summary>Clinical background : Weight loss common problem patient suffer gastrointestinal cancer . It demonstrate prognosis cancer patient weight loss bad weight stable patient . Malnutrition cancer patient associate poor prognosis important predictor mortality . Supplementation home parenteral nutrition aphagic terminal patient show improved quality life , energy balance , body composition prolong survival . Aim : The aim study primarily study effect supplementation parenteral nutrition , patient advance incurable gastrointestinal cancer lean body-mass body composition . Patients find nutritional risk include study randomize either best supportive nutritional care best supportive nutritional care supplemental Parenteral Nutrition . Design : This study control , randomize trial two parallel study arm . The study include patient advanced GI cancer nutritional risk , performance status 0-2 expect survival minimum 3 month . A total 100 patient plan enrol randomize either best supportive nutritional care best supportive nutritional care supplemental parenteral Nutrition . Primary endpoint improvement lean body mass , improvement quality life , performance status cancer treatment tolerance . Discussion : The plan study provide important information effect parenteral nutrition patient group advance gastrointestinal cancer . Palliative treatment strategy set improve quality life well prolongation life . Parenteral nutrition patient group may indeed contribute aspect palliation .</brief_summary>
	<brief_title>Study Parenteral Nutrition Patients With Gastrointestinal Cancer</brief_title>
	<detailed_description>Randomizing . The patient enrol study , block randomize use computer generate list , stratify respect performance status 0 1 opposite PS 2 first 10 patient enrol study . To make two treatment group comparable , patient number 11-100 enrol study place treatment group use minimization method . Using minimization method prognostic factor age , diagnosis performance status enrollment , consider make treatment group similar .</detailed_description>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<criteria>Histologically confirm nonresectable GICancer nutritional risk ; lose 5 % body weight previous 3 month fail reach intake 25 % last 2 week . At performance status 02 Life expectancy 3 month . Age 18 year old . Able give write consent Gastrointestinal obstruction failure . Immune deficiency disease ( apart cancer disease . ) Current infection sepsis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Bioelectrical impedance</keyword>
	<keyword>Parenteral nutrition</keyword>
	<keyword>Malnutrition</keyword>
	<keyword>Quality life .</keyword>
	<keyword>Cancer cachexia</keyword>
	<keyword>Body composition</keyword>
</DOC>